UCLA Health Systems, Blood & Platelet Center – FDA 483, May 29, 2019
An FDA inspection of UCLA Health Systems, Blood & Platelet Center in Los Angeles, CA, revealed significant failures to follow written standard operating procedures. The firm did not adhere to its SOPs for managing adverse donor events, including timely follow-up with donors and completing required attempts for severe reactions. Additionally, compliance reviews for occurrence management reports were not completed within the specified timeframe, indicating systemic issues with recordkeeping and quality management.
ID · 638f3c29-29a9-4af6-9e4b-1e0f840a6567
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.